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1. Introduction 
Many species of lactic acid bacteria (LAB), Bacillus, and fungi such as Saccharomyces and 
Aspergillus have been used over the years in the food industry. A few have gained the 
probiotic status – defined as live microorganisms, which when administered in adequate 
amounts confer a health benefit on the host (Joint FAO/WHO, 2002) – and most of this 
belong to Lactobacillus (e.g., L. bulgaricus, L. acidophilus, L. rhamnosus, L. casei, L. johnsonii, L. 
reuteri, etc.), Streptococcus (e.g., S. thermophilus, etc.), and Bifidobacterium (e.g., B. bifidum, B. 
longum, B. breve, B. infantis) genera. Bifidobacteria is the predominant species of bacteria in 
the normal intestinal flora of healthy breast-fed newborns where they constitute more than 
95% of the total population (Yildirim & Johnson, 1998). Numerous Bifidobacterium strains 
have gained recognition as probiotics because of their various therapeutic health benefits, 
including resistance to enteric pathogens (Clostridium spp., Salmonella spp., Candida spp., 
Escherichia coli spp. and Listeria monocytogenes), aid in lactose digestion and/or help to 
regulate digestion, anti–colon cancer effect, the immune system modulation, anti-allergy, 
and hepatic encephalopathy (Jia et al., 2010), and also for having a protective effect against 
acute diarrhoea (Liepke et al., 2002). The food industry recognized the market potential of 
the numerous strain-specific positive health benefits of the bifidobacteria cultures, namely in 
beverages. Bifidobacteria can also be administered as capsules or tablets or incorporated 
into food as dietary adjuncts and into baby foods (Lourens-Hattingh & Viljoen, 2001; 
Patrignani et al., 2006). In addition, bifidobacteria lower inositol phosphate content during 
bread making (Palacios et al., 2008).  
Several investigators have speculated that the survival of most bifidobacteria is not 
exceptionally high in most dairy products due to low pH and/or exposure to oxygen. 
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Nevertheless, problems may arise as a consequence of the difficulties of isolation and 
cultivation of bifidobacteria. Only a few studies have been published concerning the 
isolation and characterization of plasmids from bifidobacteria. The human 
gastrointestinal (GI) tract is the largest tube, running through the body and which 
include mouth and/or oral cavity, oesophagus, stomach, small intestine and large 
intestine. (Figure 1). 
 
Figure 1. The human gastrointestinal tract and its microbiota. 
1.1. The oral cavity 
Ingested foodstuff first comes into contact with the oral cavity, which is composed of 
different niches of microbial population. In the oral cavity, bacteria are the main group of 
microorganisms, although viruses and yeasts can also be found. The main ecological 
habitants of the mouth are the mucosa of lips, cheeks and palate, the tongue, the tooth 
surface, the saliva, and the tonsillar area. The population of microorganisms in each section 
is mainly dependent on the presence of oxygen and nutrients as well as the flow rate of the 
saliva (see Figure 2). The major species in the oral cavity are lactic acid bacteria of the genera 
Streptococcus, Lactobacillus and Bifidobacterium. In dental plaque and oral infections, many 
anaerobic species have been isolated, mainly Prevotella and Porphyromonas species, as well as 
Eubacterium, Actinomyces and Veillonella (Hartemink, 1999). 
The main source of nutrients and energy for oral bacteria is the ingested food, especially 
carbohydrates, which are rapidly metabolized to lactic and acetic acids by the predominant 
LAB, leading to a rapid drop in the pH of the saliva after ingestion of carbohydrates. The 
surplus carbohydrates can be incorporated into exopolysaccharides by a large number of 
bacteria and be used as energy storage compounds, or as attachment factors (Hartemink, 
1999). 
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Figure 2. Relationship between bacterial species, oxygen tension and habitat in the oral cavity. 
1.2. The oesophagus 
In quantitative terms, the oesophagus and stomach carry the lightest microbial loads in the 
human GI tract. The predominant culturable bacteria are facultative anaerobes, originating 
in the oral cavity, such as streptococci and lactobacilli, which occur in relatively small 
numbers (ca. 102 – 103 cm−2 or ml−1 of the mucosal surface or lumenal aspirate, respectively) 
(Macfarlane & Dillon, 2007). The majority of oesophageal bacteria (including the largely -
haemolytic Streptococcus species) are cultivable and are almost 104 bacteria per mm2 mucosal 
surface of the distal oesophagus (Pei et al., 2004). While the bacterial biota in the distal 
oesophagus is likely to be similar to that of the oropharynx (Kazor et al., 2003), many other 
species of Pseudomonas tolaasii, Pseudomonas influorensces, Pseudomonas syringae, Pseudomonas 
putida, uncultured Duganella, Stenotrophomonas maltophilia, Janthinobacterium lividum, 
Lactobacillus paracasei, Propionibacterium acnes, Pseudomonas Antarctica / meridiana, and 
Brevundimonas bulata exist in the oesophagus (Pei et al., 2004). Other selected members of the 
bacterial genera found in human distal oesophagus are given in Figure 1. 
1.3. The stomach 
In general, the human stomach has a remarkably low pH. The normal resting gastric juice’s 
pH is below 3.0, which prevents virtually all bacterial growth, and which is bactericidal for 
most transient species, especially the LABs. During and shortly after a meal, the pH may 
increase to values around 6.0. This will allow passing bifidobacteria to survive the gastric 
juice prior to proceeding onto the small intestine (to battle the bile salts). The resident flora 
of the gut lumen is highly acidic tolerant and consists mainly of lactobacilli and streptococci. 
In the stomach mucosa, the pH is much higher, and bacterial populations may be higher, as 
well. In addition to lactobacilli and streptococci, some other bacterial species and yeasts may 
be present (Hartemink, 1999). The gastric juice plays a significant role in digestion of 
proteins, by activating digestive enzymes, making ingested proteins unravel so that 
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digestive enzymes can alter protein down to individual amino acids. Fermentation of 
ingested carbohydrates in the stomach hardly occurs. 
1.4. The small intestine 
When the partially digested food enters the small intestine, it is mixed with intestinal 
secretions, such as bile, pancreatic enzymes and bicarbonates. The bile in particular has a 
strong bactericidal effect. Together with a strong-fluid secretion by the intestinal mucosa, 
this also prevents extensive colonization of the small intestine. Colonization usually takes 
place in crypts and blind loops. In this lower part of the small intestine, the movement is 
slightly reduced, the bile is diluted, the pH becomes more neutral, and the oxygen tension 
drops rapidly. This favours the growth and/or transit of different bacteria, initially mainly 
aerotolerant species, and in the ileum also strict anaerobes as revealed in Figure 3 
(Hartemink, 1999). There is not much carbohydrate fermentation in the small intestine in 
healthy humans, due to the flow rate and the little bacterial mass. 
In studies undertaken in pigs, it has been reported that the conditions in the small intestine 
differed widely. The pH is much higher, and the bile secretion is less abundant, which 
results in an extensive bacterial growth in the small intestine. This also results in substantial 
fermentation of ingested carbohydrates. The human body is projected to produce between 
20 to 30 g of bile salts per day to replace the loss occurring in the excreta (250 to 500 mg), 
and these are typically stored in the gall bladder (Glickman, 1980). 
 
Figure 3. Appearance of bacterial species, oxygen tension and habitat in the small intestine. 
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1.5. The large intestine 
In the large intestine, the flow rate of the digesta decreases considerably. In addition, the bile 
is even more diluted, and the pH is close to neutral. Total logarithmic counts may reach up 
to 1011 bacteria/gram contents. Higher numbers have been reported, but it is physically 
impossible to achieve a number over 1012 bacteria/gram faecal dry weight, taking into 
account the average balance of faeces and the dimensions of an average bacterium. It is 
estimated that over 400 different bacterial species reside in the human large intestine. Of 
these, about 200 have been validly described, but often non-identifiable strains are reported. 
In addition to the resident bacteria, transient bacteria are often isolated. The dominant floras 
in the large intestine are relatively stable, and they include Bifidobacterium, Bacteriodes and 
anaerobic cocci. Large variations also exist in the less dominant species, especially among 
the facultative or aerotolerant species like E. coli and lactobacilli. The numbers of the 
dominant species are also comparable in different population. Differences in counts are 
more often due to the methodology used, rather than actual differences. As in individuals, 
the counts of less dominant species differ widely between different populations. Among the 
dominant bacterial groups are members of the genera Bacteriodes, Bifidobacterium, 
Coprococcus, Peptostreptococcus, Eubacterium and Ruminococcus. Members of the following 
genera are often isolated and are available in lower numbers: Fusobacterium, Streptococcus, 
Lactobacillus, Enterococcus, Veillonella, Megasphaera, Propionibacterium and Enterobacteriaceae. 
It is indispensable to emphasize here that the principal function of the GI tract includes 
breakdown and absorption of food components and water. In general, degradation takes 
place in the upper part of the GI tract, whereas the major sites of absorption are in the lower 
part of small intestines and the large intestines. Degradation and absorption are enhanced 
by the excretion of the large number of digestive enzymes, such as glycosidases, lipases, 
peptidases and proteinases. The colon receives digesta from the intestinal ileum 
approximately 5 h after food ingestion. Thereafter, rate of motion slows progressively from 
the caecum towards the distal colon. Concurrent with this is an increase in water absorption; 
thus gut contents in the proximal colon are more or less liquid in nature but have a faecal 
like appearance distally (Hartemink, 1999). 
For most of the world’s population, the standard gut transit time is 60 h, with a variety of 23 
– 168 h. The colon itself has a capacity of approximately 500 ml with about 220 g contents. In 
general, stools weight correlates inversely with transit time. Studies with healthy volunteers 
have indicated that speeding up colonic transit times from 67 to 25 h resulted in an increase 
in stool weight from 148 to 285 g/day. Conversely, when transit time increased, stool weight 
decreases from 182 to 119 g/day (Hartemink, 1999). The differences are mainly due to 
changes in the water content of the faecal mass. 
The structure of faeces is highly variable. Bacteria may constitute up to 55% of the total 
solids, whilst fibre and other non-digested, non-fermented compounds represent less than 
17% of the weight of which about 24% is soluble material. Faecal water content may be as 
high as 70% of the total weight. Stool size is influenced by both dietary and endogenous 
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factors. Endogenous factors mainly operate through hormones on the intestinal motility. 
The well-known endogenous factors include: decreased peristaltic movements during 
exercises and menstrual cycle. Dietary factors, like non-digestible fibres and polyalcohols 
(sorbitol), may retain water and thus increases stool bulk. High amounts of these factors 
may cause diarrhoea, due to the increased osmotic pressure. 
2. Screening and isolation procedures of bifidobacteria strains 
Molecular methods have shown that the average percentage of bifidobacteria in the GI tract 
of humans is approximately 3% of total microbiota, or they occur at a concentration of 109 – 
1010 CFU/g of faeces (Jia et al., 2010). As to achieve intestinal colonization in humans or 
animals, bifidobacteria have to endure inhibitory substances secreted by the host, such as 
gastric acid in the stomach and bile salts (in the small intestine). Although, both the gastric 
pH (pH < 3) and bile salts are strongly bacteriocidal, some resistant bifidobacteria can 
handle the low pH’s ranges of the stomach and also survive the effects of bile salts in the 
small intestine of humans. These can be isolated and screened for their leading roles as 
probiotics. 
2.1. Isolation and cultivation of bifidobacteria resistant to acidic pH and bile 
salts 
2.1.1. Isolation via stress-shock procedure 
Selection of acid and bile resistant bifidobacteria has been based on the stressing isolation 
method developed by Chung et al., (1999). Faecal samples are collected from infants 
and/or adults. The tube containing the faecal sample is promptly screened for the isolation 
of resistant strains, as follows: Faecal samples (0.8 g each) are inoculated into 8 ml of 
Transga-lactooligosaccharide-propionate (TP) medium as an enrichment medium for the 
bifidobacteria. After an anaerobic incubation for 12 h at 37 °C, 0.8 ml of the incubated 
cultures is transferred into fresh TP medium with pH adjusted to 2.0 and incubated 
anaerobically for another 12 h at 37 °C. After the acid exposure, an aliquot (0.8 ml) of the 
incubation medium is transferred into fresh TP medium supplemented with 1.5% ox-gall, 
and the incubation continued for another 2 h at 37 °C. The resulting incubation medium is 
serially diluted and plated on TP agar, to select colonies of the resistant bifidobacteria 
strains. To isolate reference strains, serially diluted Bifidobacterium cells grown in the 
regular TP medium are plated on TP agar medium. In most of the isolation studies, B. 
adolescentis, B. longum, B. infantis, B. bifidum and owner identified Bifidobacterium strains 
(commonly called “own isolates” in microbiology) are used as reference strains. The 
reference strains are utilized for the convenience of comparison to the resistant strains. 
Microscopic analysis (1000  with immersion oil) is routinely performed to confirm 
Bifidobacterium morphology.  
In addition, Bifidobacterium cells are examined for their biochemical and morphological 
characteristics according to the Bergey’s Manual of Determinative Bacteriology. The cultures 
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are grown in Man, Rogosa, and Sharpe (MRS) medium under anaerobic conditions, in a 
microprocessor-controlled anaerobic chamber. Cultures are incubated for 18 h at 37 °C and 
stored at 3 – 5 °C between transfers. For the fermentation test, 0.5 ml of 10% substrate 
solutions (which were membrane filtered through 0.45 µM filter), are added to 9.5 ml of 
Peptone Yeast-extract Fildes (PYF) basal medium (Mitsuoka, 1990). After 2.5 days of strictly 
anaerobic incubation, the pH of the growth medium is measured. Tubes showing pH values 
below 5.5 are considered to be positive for fermentation. The presence of acetate and lactate 
in the fermented PYF containing glucose medium is assayed by using gas chromatography 
(GC) or high performance liquid chromatography (HPLC). 
2.1.2. Isolation and screening via stress-shock  
Briefly, faecal samples of 3 to 5 days old new-born babies are collected and taken to the 
laboratory for immediate analysis and isolation of bifidobacteria. About 2 g of each faeces 
sample is placed in a sterile test-tube (30 ml) and closed tightly with a rubber-stopper. For 
optimal survival of these highly sensitive anaerobic bacteria, the samples are treated within 15 
min after faeces emission, or else the samples are kept in an anaerobic environment until 
analysis (maximum of 10 h). Screening for the isolation of resistant strains is as follows: faecal 
samples (2 g each) are inoculated into 10 ml test-tubes of Raffinose-Bifidobacterium (RB) broth 
(pH 6.8). After an anaerobic incubation for 12 h at 38.5 ºC, 1 ml of the incubated culture is 
transferred into 10 ml of fresh RB medium with pH adjusted to 3.0 and incubated 
anaerobically for 2 h at 38.5 ºC. After the acid exposure, an aliquot (1 ml) of the incubation 
medium is transferred into 10 ml of fresh RB medium supplemented with 1% ox-gall, and the 
incubation continues for another 2 h at 38.5 ºC. The resulting incubation medium is serially 
diluted (10-folds) in a pre-reduced Ringer solution with 5 – 10% glycerol for the inhibition of 
the cellulolytic activity of the fungus. An aliquot of 100 µl from each dilution is plated directly 
on RB and MRS agars using the surface streak method and incubated anaerobically at 38.5 °C 
for 3 – 4 days to determine colonies of the resistant Bifidobacterium strains. 
Likewise, the isolate designated B. longum GB-03 was isolated from a pharmaceutical 
product called Golden Bifid (containing a combination of unspecified Bifidobacterium spp., 
Streptococcus thermophilus and Lactobacillus bulgaricus) using a similar approach. The first step 
is crucial to reveal that a single piece (0.5 g) has to be dissolved in 0.2 ml test-tube of 
sterilized distilled water before being inoculated into 10 ml test tube of fresh RB-medium.  
3. Morphological identification of bifidobacteria by phase contrast 
microscopy (PCM) 
In the morphological analysis of bifidobacteria population, in situ, in human faeces and/or 
other foods products, microscopes have been used to determine the degree of heterogeneity 
of these probiotic’s populations. The morphology of bifidobacteria determined 
microscopically has been used as an aid to phenotypic differentiation within the group, 
while the effect of medium type, low pH and high bile salt concentrations on the 
bifidobacterial cell morphology has also been studied by this method. Individual 
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Bifidobacterium strains are characterized phenotypically, including morphology 
identification by phase contrast microscopy (PCM). 
Bifidobacteria are gram-positive, anaerobic, rods of various shapes (short, regular, thin cells 
with pointed ends, coccoidal regular cells, long cells with slight bends or protuberances) or a 
variety of branching (pointed, slightly bifurcated, club-shaped or spatulated extremities), 
single or chains of various arrangements (in star-like aggregates or disposed in “V” or “Y” 
or else “palisade” arrangements) (Scardovi, 1986). 
As a pattern to characterize the heterogeneous population of bifidobacteria associated with 
human origin and other sources, the PCM examinations and two different media (RB & 
modified MRS) were used to demonstrate a better phenotypical correlation of the natural 
isolates to the reference strains on RB, MRS and modified MRS media as shown in Figures 
4.1 – 4.12). These media are unique and appear to be still the most predominant in culturing 
the bifidobacteria strains. 
Isolates of bifidobacteria are normally cultured anaerobically on appropriate agars at 38 ºC for 
3 – 4 days. For gram-staining, a loopful of the culture is streaked on microscope slides (46 × 25 
mm) and the staining technique followed thoroughly. Subsequently, the slide is observed 
under phase contrast microscopy, preferably at 1000  magnification by oil immersion and 
can be photographed as well, using the images advanced software package if available. 
3.1. Morphological characterization of Bifidobacterium reference strains 
The basic morphologies, namely short, regular, thin cells with pointed ends, coccoidal 
regular cells, and long cells with slight bends or protuberances are discernible among the 2 
Bifidobacterium reference strains (B. adolescentis and B. infantis) shown in Figures 4.1, 4.2, 4.3, 
4.4 and 4.11) on modified MRS and RB media. From these micrographs alone, it is obvious 
to validate that individual variations of the average phenotypic morphologies of 
bifidobacteria are present as described earlier. The PCM also provided a rapid and clear 
visualization of the basic bifidobacteria cell morphology, while at the same time, allowed 
only broad comparisons amongst the bifid structures within a mixture of 2 other LABs 
(Streptococcus thermophilus & Lactobacillus bulgaricus) (see Figure 4.12). 
The typical colonies of bifidobacteria are altogether round and white on RB and modified MRS 
media. Colonies are usually picked off of a suitable plate and may be kept sub-cultured 2 – 3 
times on a freshly prepared agar as to obtain pure culture without contamination. The 
morphologies of the 2 reference strains and their relationship to each will now be discussed 
separately. When the strain of B. adolescentis is resuscitated and cultured on modified MRS 
medium (Figure 4.1) or RB medium (Figure 4.2), it may be differentiated clearly from the B. 
infantis (Figures 4.3 & 4.4) on the basis of morphology. The B. infantis was also resuscitated and 
cultured under the similar conditions. As it can be observed from Figure 4.2, B. adolescentis on 
RB displayed long and thick rod-shaped and regular coccoidal cells. The cells of B. adolescentis 
strain on RB were almost paired and assembled, a feature which was highlighted by PCM. The 
existence of distinct “V”- and/or “Y”-shapes and some long cells with protuberances or slight 
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curvature of this isolates when grown on RB agar, is a powerful diagnostic feature, particularly 
when distinguishing this specie from closely related B. minimum when grown on Trypticase-
Phytone-Yeast extract (TPY) agar stabs (Biavati et al., 1982). In addition, curved cells with 
smooth and rounded ends are the most one dominating in the micrograph. These features 
were not compatible with descriptions of this particular species’ morphology as described by 
Reuter (1963), but were common to other species of the genus.  
The B. infantis strain displayed slender, often short rod-shaped and of the typical club-
shaped extremities, which cells of these species are reported to exhibit (see Figures 4.3 & 
4.4). The morphology of this strain is almost the same when grown on both the MRS and RB 
solid growth media. Furthermore, B. infantis showed a distinct tendency for chain formation 
on RB medium. These cells often occurred in “V” and “Y”-shapes and were similar to that of 
many other species of the genus. Nevertheless, it was also possible to differentiate between 
this strain and the closely related B. longum GB-03 (own isolate, Fig. 4.6) on the basis of small 
variety of club-shaped extreme morphology. 
3.2. Morphological differentiation of isolates of bifidobacteria  
Morphological consistency is greater among the Bifidobacterium isolate (B. longum GB-03 and 
B. bifidum WN-04) as shown in Figures 4.5 to 4.11) than the Bifidobacterium reference strains. 
Cell shapes ranged from long and thick–rods with protuberances to long and thin–rods with 
blunted ends and slightly bifurcated club-shaped extremities, with a number of variations 
on these basic shapes. Two morphological groups and their potential significance are 
discussed separately below. 
3.2.1. Long and thick–rods with protuberances cell morphology 
Figures 4.6 and 4.8 display both isolates of B. longum GB-03 and B. bifidum WN-04 on RB 
medium, which consisted of long and thick cells with slight bends. The regular morphology 
of these cells and the star-like aggregates arrangement (Figure 4.6) was evident under the 
PCM when grown on RB agar. Also, the presences of sparsely distributed single cells were 
also evident under the PCM (Figure 4.8). The morphology of these cells was consistent with 
any of the Bifidobacterium reference strains discussed previously. The isolates’ morphologies 
resembled the reference strain of B. infantis which are never elongated but have a penchant 
for group formation (Figure 4.4). 
Although no conclusions could be drawn on the basis of morphology alone, the presence of 
“V”-shaped rods, protuberances with a large variety of bending in B. bifidum WN-04 isolate 
appeared to resemble the reference strains of B. bifidum, especially the “amphora-like” cells 
that are characteristic (Sundman & Bjorksten, 1959). On the RB media, PCM analysis 
allowed a better correlation of the natural isolates to the reference strains. Speciation of B. 
longum GB-03 (in Figure 4.6) conversely appeared to favour the reference strain of B. longum, 
especially the ultra-elongated and relatively thin cellular elements with slightly irregular 
contours (Reuter, 1963). 
 
Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes 290 
 
Phase Contrast Micrographs of Bifidobacterium reference strains: Fig. 4.1, B. adolescentis on modified 
MRS; Fig. 4.2, B. adolescentis on RB; Fig. 4.3, B. infantis on modified MRS and Fig. 4.4, B. infantis on RB, 
taken at 1000  magnifications. 
 
Phase Contrast Micrographs of the isolate strains: Fig. 4.5, B. longum GB-03 on modified MRS; Fig. 4.6, 
B. longum GB-03 on RB; Fig. 4.7, B. bifidum WN-04 on modified MRS and Fig. 4.8, B. bifidum WN-04 on 
RB, taken at 1000  magnifications. 
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Figure 4. Phase Contrast Micrographs of Bifidobacterium strains: Fig. 4.9, B. bifidum WN-04 on 
unmodified MRS; Fig. 4.10, B. longum GB-03 on unmodified MRS; Fig. 4.11, B. infantis on unmodified 
MRS and Fig. 4.12, B. longum GB-03 and an assortment of other 2 Lactic Acid Bacteria (Streptococcus 
thermophilus & Lactobacillus bulgaricus), taken at 1000  magnification. 
3.2.2. Long and thin–rods with blunted ends cell morphology  
This was the most common type of morphology encountered among the Bifidobacterium 
isolates of B. longum GB-03 and B. bifidum WN-04 on the unmodified MRS agar (Figures 4.5, 
4.7, 4.9 & 4.10). Since only the general cell structure was used to differentiate this species 
from the other bacteria, PCM proved sufficient for this purpose. Variations of morphology 
within these small groups were visible under PCM as indicated by the following examples. 
The isolate of B. longum GB-03 in Figure 4.12 exemplified the diversity of rods and coccus 
cells morphology including bifid structures also; with the absence of any coccus build cells 
when grown on RB agar in Figure 4.6. By comparison with the reference strains, the cells 
morphology of B. longum GB-03 isolate is more peculiar to that displayed by B. infantis 
(Figure 4.4) and the isolate of B. bifidum WN-04 (Figures 4.7 & 4.8). All the Bifidobacterium 
isolates displayed long and short club-shaped rods, most of which were long and thin with 
blunted ends and of conventional “V” and/or “Y”-shaped cells. 
3.3. Confirmation of identity of Bifidobacterium strains 
3.3.1. Fructose-6-Phosphate Phosphoketolase (F6PPK) verification test  
F6PPK is certainly a key enzyme in the “bifidus pathway” and it allows the discrimination 
of the specific feature on expression of fructose-6 phosphate in cellular extracts that assigned 
the bifidobacteria to the genus level (Sgorbati, 1979).  
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The procedure to test for the F6PPK activity in the Bifidobacterium strains is still practised as 
described by Scardovi (1986). In brief, cells harvested from 10 ml RB or MRS broth are 
washed twice with 50 mM phosphate buffer (pH 6.5). The cells are disrupted by sonication 
in the cold, and 0.25 ml of each of NaF and Na iodoacetate solution and fructose-6-
phosphate (Na Salt: 70% purity) are added to the sonicate. The reaction is stopped by the 
addition of 1.5 ml of hydroxylamine HCl, and 1 ml each of trichloroacetic acid and 4 M HCl. 
Finally, 1.0 ml of a colour-developing agent (FeCl3.6H2O 5% (w/v) in 0.1 M HCl) is added. A 
tube without fructose-6-phosphate serves as a blank, to facilitate the visual comparison. The 
formation of acetyl phosphate from fructose-6-phosphate, shown by the reddish violet 
colour formed by the ferric chelate of its hydroxamate is an indicator for F6PPK. This is the 
distinctive and key enzyme of the "bifid shunt" that characterizes the genus. There are three 
subtypes of F6PPK in bifidobacteria as shown in Figure 5. 
3.3.2. Determination of acetic and lactic acids 
One possible method of validating the presence of acetic and lactic acids in the fermented 
milk by bifidobacteria can be assayed by using High Performance Liquid Chromatography 
(HPLC). Samples for this analysis are prepared by using a modified method described by 
Dubey & Mistry, (1996). 
 
Figure 5. Fermentation of hexose for carbohydrate metabolism (the "bifid shunt"), based on Schlegel 
(1993), where PK, phosphoketolase; TA, transaldolase; TK, transketolase, Ac~P, acetyl phosphate; GAP, 
glyceraldehydes-3-phosphate.  
The strains were maintained anaerobically by propagation in MRS broth (peptone: 10 g/l; 
meat extract: 8 g/l; yeast extract 5 g/l; D(+)glucose: 20 g/l; di-potassium hydrogen phosphate: 
2 g/l; di-ammonium hydrogen citrate: 2 g/l; Tween-80: 1 ml/l; sodium acetate: 5 g/l; 
magnesium sulfate: 0.2 g/l; manganese sulfate: 0.04 g/l, supplemented with 0.05% (w/v) 
cysteine-hydrochloride).  
The production of acetic and lactic acids, spore formation, aerobic and anaerobic growth, 
gram reactions, motility, gas production from lactose and carbohydrates fermentation tests 
are some of the confirmation tests that proves highly diagnostic personality characteristics 
of different Bifidobacterium spp as summarized in Table 1. Furthermore, the taxonomy of 
bifidobacteria has changed ever since they were first isolated. They had been assigned to the 
genera Bacillus, Bacteroides, Nocardia, Lactobacillus and Corynebacterium among others, before 
being recognized as a separate genus in 1974.  
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Many of the Bifidobacterium species groupings are heterogeneous and the entire genera have 
been re-examined using DNA-DNA hybridization. A point is made here that, instant 
phenotypic characterization of most bacteria within their respective genera relies on 
biochemical tests such as the proportion of acetic and lactic acid relative to the end product 
of metabolism; the ratio of acetic and lactic acid produced; some key carbohydrate 
fermentations; colonies and phenotypic morphologies; and the presence of fructose-6-




B. bifidum(1) B. longum(1) B. infantis(1) B. adolescentis(2) 
Spore forming – – – – 
Motility – – – – 
Gram reaction + + + + 
Morphology: rods, 
pleiomorphic 
+ + + + 
Anaerobic growth + + + + 
Aerobic growth – – – – 
Gas from lactose – – – – 
Catalase – – – – 
F6PPK + + + + 
Acetic and lactic 
production (ratio 3:2) 
+ + + + 
Carbohydrates Fermentation Test 
Cellobiose – + – + 
Fructose + + + + 
Fructooligosacharides – + + + 
Galactose + + + + 
Glucose + + + + 
Isomaltose – + + + 
Lactose + + + + 
Maltitol(3) – – – – 
Mannose – – – – 
Melezitose – – – – 
Raffinose + + + + 
Stachyose + + + + 
Trehalose – – – – 
Xylose – + – + 
Legends on Table 1: (1) Obtained from American Type Culture Collection, Rockville, USA. (2) Obtained from China 
General Microorganisms Culture Collection Center, Beijing, China. (3) Maltitol is still widely used as a non-cariogenic 
sweetener and sugar substitute but is as yet not used as a possible prebiotic. + positive results or fermentation; − 
negative results or no fermentation observed. F6PPK (fructose-6-phosphate phosphoketolase). 
Table 1. Phenotypic characteristics of some of the pH- and bile salts-resistant bifidobacteria tested. 
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4. Common media used in isolation and detection of bifidobacteria 
Many different media for bifidobacteria are outlined in Table 2. 
 
Medium Selectivity based on٭ Used for   
Acetylglucosamine-Lactose (AL) agar lactose, acetylglucosamine faeces 
AMC-agar 
nal, polymyxin B, kan, iac, TTC, LiCl, 
prop 
B. longum 
Bifidobacterium selective (BS) agar LiCl, neo, paro, prop faeces 
Bifidobacterium selective medium (BBM-agar) nal, rifampicine, raffinose faeces 
Bifidus Blood Agar aniline blue, blood faeces 
Bif-medium 
human whey, nal, paro, aztreonam, 
netilmycin 
dairy products 
Bifidobacterium Iodoacetate Medium (BIM-25 
agar) 
kan, nal, iac, neo, polymyxin B sewage 
BS-agar LiCl, neo, paro, prop faeces 
China Blue (CB) agar specific impact of china blue faeces 
GL-agar galactose, LiCl dairy products 
Liver Cysteine Lactose (LCL) agar lactose, liver infusion faeces 
LP agar lactose, LiCl, prop dairy products 
Modified Rogosa agar neo, paro, prop, LiCl dairy products 
MPN-agar lactose, nal faeces 
MRS-LP-agar prop, LiCl dairy products 
Neomycin Paromomycin Lithium Nalidixic acid 
(NPLN) agar 
LiCl, nal, neo, paro, prop faeces, dairy products 
Propionate or Beerens agar propionic acid, pH 5.0 faeces 
Raffinose-Bifidobacterium (RB) Agar raffinose, LiCl, propionate faeces, dairy products 
RCM (modified) low pH dairy products 
RCM + stain Loeffler’s methylene blue stain dairy products 
Rogosa agar low pH faeces, dairy products 
Rogosa (modified) neo, paro, prop, LiCl dairy products 
Rogosa-N low pH, nal faeces 
Tomato Casein Peptone Yeast Agar (TCPY) tomato juice faeces 
Transgalactosyloligosaccharide (TOS-Agar) TOS faeces, dairy products 
TOS-Agar (modified) TOS, nal, neo, paro dairy products 
TPYd-agar dicloxacillin dairy products 
TTC-agar TTC faecal contamination 
VF-agar (modified) LiCl, prop, neo, sodium lauryl sulfate dairy products 
YN-6 agar lactose, nal, neo, bromocresol green faeces, sewage 
Legends on Table 2: ٭iac = iodoacetic acid, kan = kanamycin, LiCl = lithiumchloride, nal = nalidixic acid, neo = 
neomycin, paro = paromomycin, prop = propionate, TOS = transgalactosyl oligosaccharides, TTC = 2,3,5-triphenyl-
tetrazoliumchloride 
Table 2. Popular media used for the enumeration of bifidobacteria from faeces, dairy- and 
pharmaceutical products, (Adapted from prebiotic effect on non-digestible oligo- and polysaccharides 
by Hartemink, 1999). 
Media used for the detection of bifidobacteria can be classified in 5 different groups. These 
are non-selective medium (such as MRS and Rogosa), medium without antibiotics but with 
elective carbohydrate, medium with antibiotics, medium with propionate, and medium 
with elective substance and/or low pH (Table 3). 
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Medium Group ٭ 
Acetylglucosamine - Lactose (AL) agar 2 
Bifidobacterium selective (BS) agar 3, 5 
Bifidobacterium selective medium (BBM) agar 2, 3 
Bifidus Blood agar 5 
Bifidobacterium Iodoacetate Medium (BIM-25) agar 3 
China Blue agar 5 
Liver Cysteine Lactose (LCL) agar 2 
Rogosa agar 1 
Modified Rogosa agar 3, 5 
MPN-agar 2, 3 
MRS 1 
MRS agar with LiCl and antibiotics (MRS-NN) 3, 5 
Neomycin Paromomycin Lithium Nalidixic acid (NPLN) agar 3, 4 
Propionate agar or Beerens agar 4 
Raffinose-Bifidobacterium (RB) agar 2, 4 
Reinforced Clostridial agar with Cephalothin and blood (RCB) 3 
Tomato Casein Peptone Yeast agar (TCPY) 5 
Tomato Casein Peptone Yeast agar (TPCY) with azide 5 
Tomato Casein Peptone Yeast agar (TPCY with sorbic acid 5 
Tomato Casein Peptone Yeast agar (TPCY with antibiotics 3 
Transgalactosyloligosaccharide (TOS - agar) 2 
TTC-agar 5 
x-Gal medium 5 
YN-6 agar 2, 3, 5 
Legends on Table 3: 
٭
group: 1 = non selective medium, 2 = medium without antibiotics but with elective carbohydrate, 
3 = medium with antibiotics, 4 = medium with propionate, 5 = medium with elective substance and/or low pH 
Table 3. Media used for the detection of bifidobacteria from faeces (Source: Hartemink, 1999). 
Combinations and media belonging to more than one group are also used. From the large 
number of media used, it can be concluded that there is no standard medium for the 
detection of bifidobacteria. Bifidobacterium spp. in the GI tract of humans are normally 
present in an adequate amounts and estimated to be between 109 and 1010 colony forming 
units (CFU) per gram wet weight or around 3% of total microbiota (Jia et al., 2010). 
However, the selectivity of independent media for the quantification of bifidobacteria is 
thoroughly examined and tested with different baby faeces. 
The experimental results of 3 media (PROP, RB and NPLN) tested on bifidobacteria show a 
wide variation in counts for the different samples (see Figure 6). Absolute counts are highest 
for the faecal samples on NPLN, followed by RB in 8 of 9 samples. PROP showed the lowest 
counts. However, as it can be observed from the same Figure 6, the principal difference 
between these 3 media is exceedingly little, actually less than one log unit. 
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Figure 6. Counts (log CFU/gm wet weight) on PROP, NPLN and RB media in babies’ faeces. 
Selectivity is also determined by microscopic observations of all different colony 
morphologies on all countable (between 10 and 150 colonies/plate) plates (see Table 4). 
Based on morphologies, selectivity is highest for babies’ faeces with NPLN with 29% false 
positive colonies (growth, but no bifidobacterial morphology). PROP showed 39% false 
positive and RB with 50% false positives. False negatives (non-typical colonies, but bifid 
morphology) can be determined on RB, as this is the only medium for which typical colonies 





 n typical non-typ. b 
RB pos c 24 12 12  (50) 
RB neg 4 0 4  (0) 
PROP 18 11 7  (39) 
NPLN 28 20 8  (29) 
Legends on Table 4: b number in brackets is the percentage of false positive (typical colony, non-typical morphology) or 
false negatives (non-typical colony, typical morphology) of the colonies tested. c pos = colonies showing characteristics 
for bifidobacteria, neg = colonies not showing characteristics for bifidobacteria. Bifidobacteria characteristics were 
defined as yellow-green colonies with a yellow halo. This attribute could only be determined on RB, as no 
characteristics were defined for other media.  
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Most false positive colonies are reported to be different cocci (mono-, diplo- or streptococci), 
spore-forming rods and short rods. No yeast is observed on any of the media tested. Based 
on the actual counts, selectivity can only be determined for RB, as the colonies of 
bifidobacteria and non-bifidobacteria cannot be determined for the other media and not all 
colonies are tested for their morphology. Selectivity as percentages of non-typical colonies 
ranges from around 5 – 7%. 
Colonies of different shapes can be tested microscopically. Bacterial morphology is 
determined, and typical and non-typical morphology is also determined. Typical 
morphology of bifidobacteria is branched or bifid-shaped rods. For the determination of 
bifidobacteria, none of the 3 media tested was decidedly selective. In this study, the 
occurrence of false positive or false negative colonies was determined. The lowest incidence 
of potential false positive colonies was observed on NPLN, but in all 3 media, the number of 
non-bifidobacteria capable of growing on the selective media was remarkably high. When 
many different species are capable of growing on the medium, an increase of one of these 
species may result in serious mistakes in calculating bifidobacteria. NPLN and RB gave 
slight higher counts than PROP. The incidence of false positive, based on morphologies on 
RB was comparable with that on the PROP and slightly higher than that on NPLN. The 
incidence of competitive flora was relatively low (less than 10% of the total colonies on the 
plates), as bifidobacteria are one of the main groups of intestinal bacteria in humans. 
PROP medium has been described as the best medium for the determination of bifidobacteria 
by Silvi et al., (1996), but they also concluded that the total bifidobacterial counts were 
significantly lower on PROP than on the other media tested. Similarly, Favier et al., (1997) 
concluded that PROP underestimated bifidobacteria in some of their samples. Both studies 
used human faeces as the test substrate. Several other studies, in which PROP agar is used, 
also show significantly lower bifidobacterial counts than most other studies (Favier et al., 1997). 
NPLN, which has been described as the medium of choice to choose bifidobacteria in dairy 
products, showed many cocci. This was in accordance with results observed by Silvi et al., 
(1996). In the same study, BIM-25 was tested, and this medium was found to be non-specific. 
All these 3 media performed reasonably well for human faeces and bifidobacteria can 
reliably be counted. The typical colonies morphological trait and the basic cellular-
morphology of bifidobacteria were demonstrated well by RB media, with reference to 
NPNL and PROP medium. The RB medium presented strains with double thickness 
diameter and more bifurcated cellular morphology under phase contrast microscopy. 
5. Experimental procedures for the enumeration of bifidobacteria and 
determining microbial inactivation by low acidic pH or bile salts 
LAB or bifidobacteria strains can be selected or isolated from commercial or alleged “own 
isolates” strains, from freeze-dried cultures which are resuscitated to stationary phase in 
MRS broth at a ratio of 2% of the volume of the fresh broth. Decimal dilutions are put onto 
Raffinose–Bifidobacterium (RB) agar plates whose pH had to be adjusted to 6.8 – 7.0 with 2 
 
Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes 298 
N NaOH. The agar plates are then incubated anaerobically at 38.5 ºC for 3 – 4 d and number 
of colony forming units (CFU)/mL are determined. Two hundred microliters of each strain 
containing about 108 CFU/mL is aseptically transferred into test tubes containing 9 mL of 
diluted MRS medium with pH adjustments of 3.0, 3.5, 4.0, or 4.5, using 2 N HCl. These 
suspensions are incubated anaerobically at 38.5 ºC and numbers of survivors are determined 
after various times as shown in Figure 7 (A). Cells were harvested by centrifugation at 5 ºC, 
were washed with phosphate-buffered saline (PBS) and were re-suspended in diluted MRS 
medium without pH adjustment. After thorough mixing on a vortex mixer, the 
concentration of surviving cells is determined by anaerobic pour plate counts, using 2 plates 
of RB agar per dilution, and incubated at 38.5 ºC for 3 – 4 days. 
Similarly, treatments for the bile salts are carried out at the final concentrations of 0.15%, 
0.30%, 0.45%, and 0.60% ox-gall  in diluted MRS medium (pH 6.8), exposed to appropriate 
times as to low pH and incubated anaerobically at 38.5 ºC (see Figure 7 (B). The cells are 
harvested by centrifugation, washed with PBS, re-suspended in diluted MRS medium without 
pH adjustment, and mixed using a vortex mixer as described for acidic pH conditions before. 
Numbers of CFU of bifidobacteria surviving the lytic effect of bile salts are also determined by 
anaerobic pour plate counts on RB agar after anaerobic incubation for 3 – 4 d at 38.5 ºC. 
5.1. Characterizations for D(acid)-, D(bile)-, z(acid), and z(bile)-values 
D(acid)-value is defined as the time (in min) required at a specified acidic pH to reduce the 
number of cells by 90%, while D(bile)-value is defined as the time (in min) required at a 
specified concentration of bile salts to reduce the number of cells by 90%. In fact, the D(bile)-
value of any LAB or bifidobacterial strain is directly proportional to the bile salt 
concentrations, while the D(acid)-value is inversely proportional to the acidic pH.  
The z(acid) and/or z(bile)-values, on the other hand, is defined as a decrease in pH value (pH < 
4.5) or an increase in bile salt concentration (% ox-bile) required to reduce the D-values by 1 
log cycle, however, respectively. The D(acid)- and D(bile)-values can be directly calculated from 
the absolute values of the reciprocal of the slopes of the linear-regression equations, using a 
Microsoft Office–Excel software. It is essential to emphasize that, the regression lines must 
be applied to all the treatments, for which restriction of the R-squared (R2) value is 
pragmatic above 0.8920. Moreover, the D(acid)- and/or D(bile)-values can also be calculated 
algebraically from the regression equation derived using the method of least-squares to be 
able to produce the z(acid)- and/or z(bile)-values for the probiotic strains. 
In order to determine the z(acid)- and/or z(bile)-values, the formula is exactly the same as that 
for heat resistance, replacing T (temperature) with pH values or bile salts (BS) 
concentrations as described by Equations (1) and (2), respectively. In both of these cases, the 
effect of acidic conditions and bile salts is determined from the reduction in concentration of 
colony-forming units. One has to pay attention that the dynamic z(acid)- and/or z(bile)-values 
are calculated for a period of exponential destruction of microbial cells (following the 
logarithmic order of death), using both Equations (1) and (2). 
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Figure 7. Schematic diagram of treatment groups for the selected bifidobacteria. A): Influence of gastric 
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Suspended in SGJ @ ambient (38.5°C). 
Bifidobacterium spp. 
Suspended in Simulated Gastric Juice (SGJ) @ ambient temp. (38.5°C).






































Treatment - 0.15% oxgall
Incubate anaerobically. 
Hold for 350, 700, 1050, 
1400, 1750, 2100, 2450 
min, respectively. 
Treatment - 0.30%  oxgall
Incubate anaerobically. 
Hold for 250, 500, 750, 
1000, 1250, 1500, 1750 
min, respectively. 
Incubate anaerobically. 
Hold for 150, 300, 450, 
600, 750, 900, 1050 min, 
respectively. 
Treatment - 0.45%  oxgall
Incubate anaerobically. 
Hold for 50, 100, 150, 
200, 250, 300, 350 min, 
respectively. 
Treatment - 0.60%  oxgall 
Centrifuge @ 3000 rmp for 15 min at 5°C. 
Wash with Phosphate-Buffered Saline. 
Re-suspend in SGJ @ pH 6.8. 
Vortex well. 
Pour and/or spread plate count on RB agar @ 38.5°C / 72 hours. 
Treatment - pH 3.0 Treatment - pH 3.5 Treatment - pH 4.0 Treatment - pH 4.5 
Centrifuge @ 3000 rmp for 15 min at 5°C. 
Wash with Phosphate-Buffered Saline. 
Re-suspend in SGJ @ pH 6.8. 
Vortex well. 
Pour and/or spread plate count on RB agar @ 38.5°C / 72 hours. 
Incubate anaerobically. 
Hold for 50, 100, 150, 
200, 250, 300, 350 min, 
respectively. 
Incubate anaerobically. 
Hold for 150, 300, 450, 
600, 750, 900, 1050 min, 
respectively. 
Incubate anaerobically. 
Hold for 250, 500, 750, 
1000, 1250, 1500, 1750 
min, respectively. 
Incubate anaerobically. 
Hold for 350, 700, 1050, 
1400, 1750, 2100, 2450 
min, respectively. 
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where z is the acid pH value (in Equation 1) or bile salts value (in Equation 2) required for a 
ten-fold reduction in D-values; pH1 is the acidic value of pH 1; pH2 is the acidic value of pH 
2; BS1 is the concentration of bile salts 1 (%); BS2 is the concentration of bile salts 2 (%); D(acid1) 
or D(bile1) is a D-value obtained at either pH1 or BS1; and D(acid2) or D(bile2) is a D-value obtained 
at either pH2 or BS2. 
5.2. Survival of bifidobacteria in simulated acidic pH of human stomach 
Figure 8 shows the survival of selected Bifidobacterium strains exposed to various acidic pH 
levels. The bifidobacterial counts (range: 5.5 – 6.7 log CFU/ml) of all four strains at pH 3.5 after 
5 h are an indication of resistance that may perhaps simulate gastric conditions. In fact, with B. 
bifidum, B. infantis, and B. longum the counts were > 2.0 log CFU/ml after exposure for 5 h, 
which indicates that these strains are relatively resistant at pH 3.0. However, as observed from 
all the experimental results in Figure 8, the B. adolescentis strain is more sensitive than the other 
three strains to all the acid treatments. For instance, numbers of B. adolescentis are 3.4 log 
CFU/ml after 10 h at pH 3.5, but below the level of exposure thereafter, while a similar count 
(~3.4 log CFU/ml) is observed with the other three strains after 12.5 h. This 2.5 h difference in 
survival at pH 3.5 is approximately the time chosen by Olejnik et al., (2005) to control acid 
resistance, as these times simulate residence time in the stomach. On this basis, this specific 
strain of B. adolescentis is considered a less-resistant strain with respect to gastric acidity. 
Many other researchers have found pH 2.0 and pH 3.0 to be lethal and sublethal pH values 
respectively for lactic acid bacteria (LAB), including bifidobacteria (Khalil et al., 2007). It is 
vital to stress that probiotics are able to confer health benefits despite the brief exposure to 
exact acidic conditions following ingestion. Although a log-scale reduction of viability may 
occur, it may still mean that a sufficient number of bifidobacteria survive the gut, depending 
on the dose. Moreover, the exposure to acid does not mean that the potential health benefits 
are lost. Some cells may die, and some may be injured. However, these cells may recover 
later, and they may also have beneficial effects on health. The mechanism may be mediated, 
for example, through the components of the cell wall of the probiotics which will then be 
available in both dead and living cells. It should be also borne in mind that, the food matrix 
in which the probiotics are consumed is likely to have a strong effect on the survival of the 
bacteria in the gut. 
In Figure 8, for example, it is possible to say that the high survival counts of B. bifidum, B. 
infantis, and B. longum exposed to pH 4.5 after 41 h is a representation of culture stability 
curves of the acid resistant strains (log CFU/ml) in a food matrix. While the pH of 4.5 does 
not represent gastric acid conditions, it is a typical representation of fermented products, 
and in such products, the survival counts are expected to last for much longer periods 
during shelf life, especially at the refrigeration temperature of 4 °C. 
5.3. Survival of bifidobacteria in simulated bile salts nature 
Resistance to bile salts is considered an intrinsic property for probiotic strains to survive the 
conditions in the small intestine. The physiological bile salt concentration in the GI tract of 
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humans is estimated to be 0.3 – 0.4% w/v (Jia et al., 2010). As shown in Figure 9, the linear 
regressions of the loss of CFU did express satisfactorily that B. bifidum, B. infantis, and B. 
longum are more-resistant strains to the bile salts. These 3 strains survived well in 0.45% 
(w/v) bile salts, with more than 4.5 log CFU/ml present after 10 h. Their capacity to survive 
high bile salt concentrations suggests the existence of defence mechanisms and confirms that 
strains showing antagonistic effect against enteric pathogens should be able to compete 
successfully with the pathogens in the GI tract. It is clear that B. adolescentis is again the less-
resistant strain encountered with only 2.8 log CFU/ml surviving after 10 h in 0.45% bile salts 
(see Figure 9). Therefore, B. adolescentis is considered the less-resistant strain, while B. 
bifidum, B. infantis, and B. longum, in that order, are considered the more-resistant. It is well 
known that, the bile salt hydrolytic (BSH) activity may be the contributing factor towards 
the resistance of the LABs and to the toxicity of conjugated bile salts in the duodenum, and 
therefore, is an essential colonization factor. 
5.4. The feasibility of D(acid)-, D(bile)-, z(acid)- and z(bile)-values for selection of 
probiotic strains and for determining the mechanisms of resistance to acid and 
bile salts stress 
Table 5, shows that accurate tabulation of the D(acid)- or D(bile)-values and their respective 
z(acid)- or z(bile)-values is tremendously helpful in evaluating the resistance and susceptibility 
of probiotics to acidic pH and high bile salt concentrations, respectively. Both the estimated 
D(acid)- and D(bile)-values validated that the most acid- and bile-resistant strain is B. bifidum 
followed by B. infantis, B. longum, and final B. adolescentis. It is also possible to observe in 
Table 5, that, increasing the bile salt concentration from 0.15 to 0.60% had a greater impact 
on survival than decreasing the pH values from 4.5 to 3.0, with the D(bile)-values of B. bifidum 
decreasing from 17.40 to 1.40 min and the D(acid)-values decreasing from 23.80 to 1.10 min. 
Similar trends are observed with all other Bifidobacterium strains. However, decreases of 
depicted z(acid)-value in the pH value (pH<4.5) or increases of depicted z(bile)-value in the bile 
salt concentrations (% ox-bile) are expected to cause a 1-log reduction in their respective D-
values. In practice, z(acid)- or z(bile)-value measures how the sensitivity of probiotic strains is to 
small changes in [H+] and/or [OH-] or bile salts. As for probiotics to gain intestinal 
colonization in humans or animals for their proclaimed therapeutic health benefits, 
obviously, they have to tolerate inhibitory substances secreted by the host, such as gastric 
acids (in the stomach) and bile salts (in the small intestine). 
Of all ions, H+ and OH− are the most mobile, and minor changes in their concentrations show 
significant effects on microorganisms. Most organisms survive better when these ions are 
present in approximately equal concentrations, that is, pH 7.0. Although many bacteria 
tolerate higher pH values, only a few are acid tolerant or acidophilic. In addition, many 
other bacteria are tolerant of small pH variations, especially in the pH range of 6.0 to 9.0. For 
instance, if the pH of the medium changes rapidly, there may be a transient change in the 
intracellular pH, and this is usually readjusted to the original pH within 30 min. 
Consequently, any damage produced by adverse pH is not actually due to the H+ and/or 
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OH−, but to the effect of these ions on the proportion of undissociated weak acids or bases, 
which penetrate more readily into the bacterial cell than the ionized forms. In contrast, bile 
salts are biological detergents synthesized in the liver from cholesterol, conjugated to either 
glycine or taurine, and are then secreted into the intestine where they facilitate fat 
absorption. Bile salts are well known to be toxic for many cells as they disrupt the lipid 
bilayer structure of the cellular membranes. Many earlier studies revealed that the 
autochthonous gastrointestinal microbiota must develop strategies to protect themselves 







Figure 8. Linear regressions of the loss of CFU for the selected bifidobacteria strains when exposed to 
simulated gastric acidity of pH 3.0, pH 3.5, pH 4.0 and pH 4.5, respectively: (a) B. bifidum, (b) B. longum, 
(c) B. infantis, (d) B. adolescentis. 
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Figure 9. Linear regressions of the loss of CFU for the selected bifidobacteria strains when exposed to 
high bile salt (oxgall) concentrations of 0.60%, 0.45%, 0.30% and 0.15%, respectively: (a) B. bifidum, (b) B. 
longum, (c) B. infantis, (d) B. adolescentis. 
The individual z(acid)- or z(bile)-values calculated from their D(acid)- and D(bile)-values ranged from 
1.11 – 1.55 pH units and 0.40 – 0.49%, respectively (Table 5). Although the combination of both 
the low acidic pH and bile salts is not assessed, it is assumed that at pH < 3.0, and 0.60% of ox-
bile, the combined effects could be more synergistic and even greater in magnitude for probiotic 
bacteria to survive. Additionally, the D(acid)- and D(bile)-values reveal a modern and efficient 
sorting order of the more-resistant probiotic strains to these two distinct hostile GI tract 
conditions in humans. Many authors have investigated the effect of bile on survival of LAB. For 
example, Kim et al., (1999) examined the effect of bile concentration in the range of 0 – 0.4% on 
survival of Lb. lactis and found bile to be toxic at concentrations over 0.04%. Shimakawa et al., 
(2003) reported that 0.2% oxgall in the growth medium inhibited growth of B. breve strain 
Yakult. Others detected that all bacterial cells were killed by 0.2% bile and higher (Olejnik et al., 
2005). However, Khalil et al., (2007) reported higher resistance to bile salts, with viability of 
strains apparently increasing when exposed to high levels of oxgall (0.4%). 
 









B. bifidum B. infantis B. longum B. adolescentis 
4.5 23.80 14.10 12.00 7.60 
4.0 8.40 6.00 5.70 3.98 
3.5 3.00 2.70 2.60 2.05 
3.0 1.10 1.10 1.20 1.10 
 z(acid)-value (in pH units)
 1.11 1.55 1.35 1.55 
Bile Salts D(bile)-value (min)
0.15% 17.40 10.50 9.60 6.80 
0.30% 7.40 5.20 4.70 3.20 
0.45% 3.20 2.55 2.30 1.58 
0.60% 1.40 1.30 1.10 0.75 
 z(bile)-value (% ox-bile concentration)







Table 5. Selected Bifidobacterium strains and their calculated D(acid)-, D(bile)-, z(acid)- and z(bile)-values. 
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As compared to previous studies, the practicality of D(acid)-, D(bile)-, z(acid)- and z(bile)-values as 
new kinetic-measurements applied in this study, are indeed, quick to identify comparably 
higher survival of bifidobacteria cells (> 4.1 log CFU/ml after 2.5 h) at elevated bile salt 
concentrations of 0.6% (w/v), thereby confirm also that the individual Bifidobacterium strains 
are resistant to harsh intestinal conditions in the following order: B. bifidum > B. infantis > B. 
longum > B. adolescentis. A number of researchers reported that B. infantis had the highest 
survival rates followed by B. bifidum, B. breve and B. longum, when exposed to bile salt at 
concentrations ranging from 0 to 3 g/l. In contrast, the literature contains also one 
preliminary report that B. longum exhibited the highest tolerance to bile salts followed by B. 
bifidum and B. infantis, which was almost the exact opposite in order of their tolerance to 
acidic pH. These contrasting observations may reflect the strain-specific resistance to acid or 
bile salts stress. It also indicates that tolerance is strain- rather than species-specific. 
Likewise, the source of isolation of the probiotic strains is particularly influential too. 
6. Conclusion 
Apart from the isolation, enumeration, unequivocal taxonomical characterization, screening 
and selection of tolerant strains of bifidobacteria to gastric acid and bile salts studies, the 
assessment of the tolerant bifidobacteria to bile salts and low pH has been made possible by 
use of D- and z-value concept. After log-conversion, inactivation followed first-order kinetic 
law whereby validating the kinetic assumptions of the latter concept. The projected z(acid)- 
and z(bile)-values were all fairly similar for the bifidobacteria strains and suggested the effect 
of increasing the bile salt concentration or decreasing the pH on the D(acid)- and D(bile)-values. 
This approach is useful for measuring the resistance and sensitivity of lactic acid bacteria or 
bifidobacteria to these two hostile gastrointestinal conditions. The approach pursued in this 
chapter would be extremely useful for predicting the suitability of bifidobacteria and/or 
other LAB as probiotics for use in real life situations. While the mechanisms of probiotic 
survival in the GI tract could be more complex, the practical utility of the D(acid)- and/or 
D(bile)- and their z(acid)- and z(bile)-values is significant. 
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